China SXT Pharmaceuticals (SXTC) Interest & Investment Income (2018 - 2019)
China SXT Pharmaceuticals (SXTC) recorded quarterly Interest & Investment Income of -$2.2 million in Q3 2019, down 144707.66% quarter-over-quarter from $1501.0 in Q3 2018, and down 144707.66% on a YoY basis from N/an in Q3 2018.
China SXT Pharmaceuticals (SXTC) Interest & Investment Income (2018 - 2019) Analysis & Trends
China SXT Pharmaceuticals' Interest & Investment Income history runs 2 years deep, the most recent figure standing at -$2.2 million for Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | China SXT Pharmaceuticals | 210.01 Mn | 188.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -2.17 Mn |
| Sep 30, 2018 | 1,501.00 |